misonneh's profile

Recent Activity

• 12:35: posted Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs.

• 08:28: posted The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
• 08:28: posted The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
• 08:27: posted PharmGED: pharmacogenetic effect database.
• 08:25: posted The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
• 08:15: posted HGVbaseG2P: a central genetic association database.
• 08:13: posted The SNP Consortium website: past, present and future.
• 08:10: posted The International HapMap Project Web site.
• 08:06: posted Data integration and genomic medicine.
• 08:03: posted The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine.
• 07:59: posted UK Biobank: from concept to reality.
• 06:24: posted Feature selection and nearest centroid classification for protein mass spectrometry.
• 06:23: posted Biomarker identification by feature wrappers.
• 05:57: posted Basal-like breast cancer: a critical review.
• 05:55: posted The Nottingham prognostic index for invasive carcinoma of the breast.
• 05:49: posted MicroRNA involvement in the pathogenesis and management of breast cancer
• 05:48: posted Triple-negative/basal-like breast cancer: review.
• 05:44: posted Basal-like and Triple-Negative Breast Cancer: Definition and Therapeutic Insights - ASCO
• 05:42: posted Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
• 05:17: posted The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2--response to therapy, other indications, and future directions.
• 05:16: posted The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging

• 21:48: posted 5-methylcytosine--the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer?
• 21:44: posted Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study.
• 21:21: posted Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer.

• 06:03: posted Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors.